Acute Myeloid Leukemia, M1
|
disease |
Neoplasms
|
Neoplastic Process
|
138
|
|
0.300 |
None |
|
0 |
|
|
|
Epistaxis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Pathologic Function
|
82
|
4
|
0.100 |
None |
|
0 |
|
|
|
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Increased tendency to bruise
|
phenotype |
Wounds and Injuries
|
Finding
|
133
|
14
|
0.100 |
None |
|
0 |
|
|
|
Acute Myeloid Leukemia (AML-M2)
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
5
|
0.300 |
None |
|
0 |
|
|
|
Petechiae of skin
|
phenotype |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Sign or Symptom
|
54
|
2
|
0.100 |
None |
|
0 |
|
|
|
Infant Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
52
|
8
|
0.010 |
None |
< 0.001 |
1 |
|
1997 |
1997 |
Neoplasm of minor salivary gland
|
disease |
Digestive System Diseases; Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
2
|
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Primary central nervous system lymphoma
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
156
|
4
|
0.020 |
None |
0.500 |
2 |
|
2014 |
2018 |
Recurrent Childhood Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
37
|
|
0.020 |
None |
0.500 |
2 |
|
1998 |
2001 |
Hematological Disease
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
255
|
16
|
0.020 |
None |
0.500 |
2 |
|
1997 |
2001 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.030 |
None |
0.667 |
3 |
|
2002 |
2018 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.030 |
None |
0.667 |
3 |
|
2002 |
2018 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.040 |
None |
0.750 |
4 |
|
2014 |
2018 |
Malignant Childhood Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
179
|
34
|
0.060 |
None |
0.833 |
6 |
|
1998 |
2011 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.857 |
21 |
|
1997 |
2019 |
Eosinophilic disorder
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
288
|
22
|
0.100 |
None |
0.900 |
10 |
|
1995 |
2019 |
Eosinophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
325
|
23
|
0.100 |
None |
0.900 |
10 |
|
1995 |
2019 |
Leukemogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
996
|
25
|
0.100 |
None |
0.920 |
50 |
|
1995 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.927 |
41 |
|
1997 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.929 |
56 |
|
1995 |
2020 |
Neoplasm, Residual
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
329
|
23
|
0.100 |
None |
0.962 |
26 |
|
1996 |
2019 |
Secretory breast carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
19
|
|
0.100 |
None |
0.962 |
26 |
|
2002 |
2020 |
Mammary Analogue Secretory Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
17
|
|
0.100 |
None |
0.967 |
30 |
|
2012 |
2019 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.100 |
None |
0.970 |
100 |
3
|
1995 |
2019 |